584 related articles for article (PubMed ID: 33574819)
1. COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases.
Lakota K; Perdan-Pirkmajer K; Hočevar A; Sodin-Semrl S; Rotar Ž; Čučnik S; Žigon P
Front Immunol; 2020; 11():611318. PubMed ID: 33574819
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
3. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
[TBL] [Abstract][Full Text] [Related]
4. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis.
Gracia-Ramos AE; Martin-Nares E; Hernández-Molina G
Cells; 2021 Dec; 10(12):. PubMed ID: 34944099
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
Bakasis AD; Mavragani CP; Boki KA; Tzioufas AG; Vlachoyiannopoulos PG; Stergiou IE; Skopouli FN; Moutsopoulos HM
J Autoimmun; 2021 Sep; 123():102687. PubMed ID: 34311142
[TBL] [Abstract][Full Text] [Related]
6. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
[TBL] [Abstract][Full Text] [Related]
7. Long COVID in autoimmune rheumatic diseases.
Fedorchenko Y; Zimba O
Rheumatol Int; 2023 Jul; 43(7):1197-1207. PubMed ID: 36995436
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology.
Park JK; Lee EB; Shin K; Sung YK; Kim TH; Kwon SR; Lee MS; Hong SJ; Choi BY; Lee SS; Back HJ;
J Korean Med Sci; 2021 Mar; 36(12):e95. PubMed ID: 33783147
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review.
Tang KT; Hsu BC; Chen DY
Front Immunol; 2021; 12():645013. PubMed ID: 33777042
[No Abstract] [Full Text] [Related]
10. COVID-19 and autoimmune diseases: is there a connection?
Votto M; Castagnoli R; Marseglia GL; Licari A; Brambilla I
Curr Opin Allergy Clin Immunol; 2023 Apr; 23(2):185-192. PubMed ID: 36728317
[TBL] [Abstract][Full Text] [Related]
11. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.
Szekanecz Z; Balog A; Constantin T; Czirják L; Géher P; Kovács L; Kumánovics G; Nagy G; Rákóczi É; Szamosi S; Szűcs G; Vályi-Nagy I
Expert Rev Mol Med; 2022 Mar; 24():e13. PubMed ID: 35311631
[TBL] [Abstract][Full Text] [Related]
12. Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study.
Qian G; Wang X; Patel NJ; Kawano Y; Fu X; Cook CE; Vanni KMM; Kowalski EN; Banasiak EP; Bade KJ; Srivatsan S; Williams ZK; Todd DJ; Weinblatt ME; Wallace ZS; Sparks JA
medRxiv; 2022 Oct; ():. PubMed ID: 36324801
[TBL] [Abstract][Full Text] [Related]
13. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
Kabeerdoss J; Danda D
Int J Rheum Dis; 2020 Aug; 23(8):998-1008. PubMed ID: 32779341
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and autoimmune diseases.
Liu Y; Sawalha AH; Lu Q
Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and the clinical course of rheumatic manifestations.
Ahmed S; Zimba O; Gasparyan AY
Clin Rheumatol; 2021 Jul; 40(7):2611-2619. PubMed ID: 33733315
[TBL] [Abstract][Full Text] [Related]
16. Oral Antiviral Treatment for COVID-19 in Patients With Systemic Autoimmune Rheumatic Diseases.
Gerolymatou N; Bakasis AD; Voulgari PV; Vlachoyiannopoulos PG
J Rheumatol; 2023 Aug; 50(8):1078-1081. PubMed ID: 36521909
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 infection among patients with systemic autoimmune diseases.
Emmi G; Bettiol A; Mattioli I; Silvestri E; Di Scala G; Urban ML; Vaglio A; Prisco D
Autoimmun Rev; 2020 Jul; 19(7):102575. PubMed ID: 32376395
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
[TBL] [Abstract][Full Text] [Related]
19. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion.
Sarzi-Puttini P; Marotto D; Antivalle M; Salaffi F; Atzeni F; Maconi G; Monteleone G; Rizzardini G; Antinori S; Galli M; Ardizzone S
Autoimmun Rev; 2020 Jul; 19(7):102574. PubMed ID: 32376399
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
